NCT05210907
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
Clinical trial condition
Epstein-Barr Virus Infections
Explore clinical trials studying Epstein-Barr Virus Infections. Study availability and eligibility vary by location and protocol.
692 public trials
114 recruiting studies
Epstein-Barr Virus Infections trial results
NCT05518383
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B-cell Lymphoma, +19 more
- Locations
-
- Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology Moscow, RF, Russia
NCT04746209
- Conditions
- B-Cell ALL, Childhood, B-cell Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, +17 more
- Locations
-
- Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States
NCT03869619
- Conditions
- Burkitt Lymphoma, Burkitt Lymphoma (BL)), DNA Virus Infections, +26 more
- Locations
-
- Unité d'Hématologie Clinique, CH D'ARRAS Arras, France
- Service d'Hématologie, CHU Jean Minjoz Besançon, France
- Service d'Onco-radiolothérapie, Polyclinique Bordeaux Nord Aquitaine Bordeaux, France
- Institut Bergonié Bordeaux, France
Not Yet Recruiting
Study Of KITE-753 in R/R B-Cell ALL
NCT07674823
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- UT MD Anderson Houston, Texas, United States
Not Yet Recruiting
Testing the Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit Lymphoma
NCT07724457
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +18 more
- Locations
-
Not specified
Not Yet Recruiting
Pre-emptive Anakinra for Cytokine Event Reduction
NCT06703216
- Conditions
- B-Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CAR-T Cell Therapy, +24 more
- Locations
-
- Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
Not Yet Recruiting
Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study
NCT07662928
- Conditions
- Adult Burkitt Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Not Yet Recruiting
A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia
NCT07313852
- Conditions
- B-ALL, B-Cell Acute Lymphoblastic Leukemia, Adult, B-cell Acute Lymphoblastic Leukemia, +17 more
- Locations
-
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States
Not Yet Recruiting
Non-Interventional Study of Puzol-cel for CD19-Positive Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
NCT07637929
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +19 more
- Locations
-
Not specified